These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6345682

  • 1. Complement-activating immune deposits in systemic lupus erythematosus skin.
    Gammon WR, Merritt CC, Henke DC, Robinson T, Henley N, DeAngelo L.
    J Invest Dermatol; 1983 Jul; 81(1):14-20. PubMed ID: 6345682
    [Abstract] [Full Text] [Related]

  • 2. Activation of the alternative pathway of complement by skin immune deposits.
    Schifferli JA, Steiger G, Polla L, Didierjean L, Saurat JH.
    J Invest Dermatol; 1985 Nov; 85(5):407-11. PubMed ID: 3902986
    [Abstract] [Full Text] [Related]

  • 3. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR, Merritt CC, Lewis DM, Sams WM, Wheeler CE, Carlo JR.
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [Abstract] [Full Text] [Related]

  • 4. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT, Tomasi TB.
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [Abstract] [Full Text] [Related]

  • 5. How reliable is the basement membrane phenomenon in the diagnosis of systemic lupus erythematosus?
    al-Fouzan AS, Hassab-el-Naby HM, Dvorak R.
    Int J Dermatol; 1995 May; 34(5):330-2. PubMed ID: 7607793
    [Abstract] [Full Text] [Related]

  • 6. Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus.
    Gammon WR, Briggaman RA, Inman AO, Merritt CC, Wheeler CE.
    J Invest Dermatol; 1983 Oct; 81(4):320-5. PubMed ID: 6619561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G, Lavin L, Ziskind M, Koffler D.
    N Engl J Med; 1982 Feb 04; 306(5):264-70. PubMed ID: 7054697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Semiologic value of C1q and C4 cutaneous deposits. An immunofluorescent study.
    Gomes MA, Fernandez-Bussy R, Ohrt C, Thivolet J.
    J Cutan Pathol; 1982 Jun 04; 9(3):169-74. PubMed ID: 6752226
    [Abstract] [Full Text] [Related]

  • 11. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V, Binder WL, Schotland E, Beutner EH, Chorzelski TP.
    Arch Dermatol; 1978 Aug 04; 114(8):1187-90. PubMed ID: 354534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN, Cheatum DE, Hurd ER, Stastny P, Ziff M.
    J Clin Invest; 1974 May 04; 53(5):1434-40. PubMed ID: 4596508
    [Abstract] [Full Text] [Related]

  • 14. Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia.
    Schiødt M, Holmstrup P, Dabelsteen E, Ullman S.
    Oral Surg Oral Med Oral Pathol; 1981 Jun 04; 51(6):603-8. PubMed ID: 6942360
    [Abstract] [Full Text] [Related]

  • 15. Detection of anti-basement membrane zone antibodies in bullous systemic lupus erythematosus.
    Janniger CK, Kowalewski C, Mahmood T, Lambert WC, Schwartz RA.
    J Am Acad Dermatol; 1991 Apr 04; 24(4):643-7. PubMed ID: 2033145
    [Abstract] [Full Text] [Related]

  • 16. Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.
    Seyger MM, van Bruggen MC, Hardeman HK, van den Hoogen FH, Berden JH, van den Born J, De Jong EM.
    Acta Derm Venereol; 1998 Sep 04; 78(5):326-30. PubMed ID: 9779246
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
    Carlo JR, Rothfield NF, Ruddy S.
    Arthritis Rheum; 1979 Jan 04; 22(1):13-8. PubMed ID: 83148
    [Abstract] [Full Text] [Related]

  • 18. Skin immunopathology in system lupus erythematosus.
    Brown MM, Yount WJ.
    JAMA; 1980 Jan 04; 243(1):38-42. PubMed ID: 6985675
    [Abstract] [Full Text] [Related]

  • 19. Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus.
    Helm KF, Peters MS.
    J Am Acad Dermatol; 1993 May 04; 28(5 Pt 1):687-91. PubMed ID: 7684407
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.
    Schroeter AL, Conn DL, Jordon RE.
    Ann Rheum Dis; 1976 Aug 04; 35(4):321-6. PubMed ID: 970989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.